Abstract:Background. The rate of ovarian cancer (OC) is one of the highest in women's reproductive systems. An improperly expressed microRNA (miRNA) has been discovered to have a vital role in the pathophysiology of OC. However, more research into OC's miRNA-message RNA (mRNA) gene interaction network is required. Methods. Firstly, the microarray data sets GSE25405 and GSE119055 from the GEO (Gene Expression Omnibus) database were downloaded and then analyzed with the GEO2R tool aiming at identifying DEMs (differential expressed miRNAs) between ovarian malignant tissue and ovarian normal tissue. The whole consistently changed miRNAs were then screened out to be candidate DEMs. For estimating underlying upstream transcription factors, FunRich was employed. miRNet was utilized to determine putative DEMs' downstream target genes. The R program was then used to do the GO annotation as well as the analysis of KEGG pathway enrichment for target genes. The PPI (protein-protein interaction), as well as the DEM-hub gene networks, were created by the Cytoscape software and STRING database. Finally, we chose the GSE74448 dataset to test the precision of hub gene expressions. Results. We have screened out six (five upregulated and one downregulated) DEMs. The majority of upregulated and downregulated DEMs are likely regulated by SP1 (specificity protein 1). SP4 (s protein 4), POU2F1 (POU class 2 homeobox 1), MEF2A (myocyte-specific enhancer factor 2A), ARID3A (AT-rich interaction domain 3A), and EGR1 (early growth response 1) can regulate upregulated and downregulated DEMs. We have found 807 target genes (656 upregulated and 151 downregulated DEM), being generally enriched in focal adhesion and proteoglycans in cancer, gastric cancer, hepatocellular carcinoma, as well as breast cancer. The majority of hub genes are projected to be controlled by hsa-miR-429, hsa-miR-140-5p, hsa-miR-199a-5p, and hsa-miR-199a-3p after the DEM-hub gene network was built. VEGFA (vascular endothelial growth factor A), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), and HIF1A (hypoxia inducible factor 1 subunit alpha) expressions are consistent with the GSE74448 dataset in the first 18 hub genes. Conclusion. We have built an underlying miRNA-mRNA interacting network in OC, giving us unparalleled insight into the disease's diagnosis and treatment.

Integrated Microrna and Mrna Signatures in Peripheral Blood Lymphocytes of Familial Epithelial Ovarian Cancer.

Integrative Network Analysis Reveals a MicroRNA-Based Signature for Prognosis Prediction of Epithelial Ovarian Cancer

Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics Analysis

Construction of Mirna-Mrna Regulatory Network and Prognostic Signature in Endometrial Cancer.

Identification of a Potential Prognostic Lncrna‐mirna‐mrna Signature in Endometrial Cancer Based on the Competing Endogenous RNA Network

Identification of the Coregulated Mrna and Lncrna Functional Pathways in Ovarian Cancer Using LncRNAs2Pathways by Lncrnas Based on an Integrated Network Propagation

Establishment and Comprehensive Analysis of Underlying microRNA-mRNA Interactive Networks in Ovarian Cancer

Identification of Lncrna-Associated Cerna Network in High-Grade Serous Ovarian Cancer Metastasis

The Identification and Analysis of mRNA-lncRNA-miRNA Cliques From the Integrative Network of Ovarian Cancer.

Integrated bioinformatic analysis of dysregulated microRNA-mRNA co-expression network in ovarian endometriosis.

Protein–Protein Interaction Network Construction and Differential miRNA Target Gene Prediction in Ovarian Cancer by Bioinformatics Analysis

Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer

A microRNA–Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer

Key Nodes of a Microrna Network Associated with the Integrated Mesenchymal Subtype of High-Grade Serous Ovarian Cancer

Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer

Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis

Integrated Bioinformatics Analysis of Microarray Data from Non-Small Cell Lung Cancer.

Characterizing the landscape of peritoneal exosomal microRNAs in patients with ovarian cancer by high-throughput sequencing

Analysis of LncRNAs and mRNAs expression profiles in ovarian epithelial cancer cell lines by gene microarray

Identification of lncRNA–miRNA–mRNA regulatory network associated with epithelial ovarian cancer cisplatin‐resistant

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.